Items where authors include "Morton, A."

Article

Aad, G., Abbott, B., Abbott, D.C. et al. (5241 more authors) (2023) Combination of inclusive top-quark pair production cross-section measurements using ATLAS and CMS data at s√ = 7 and 8 TeV. Journal of High Energy Physics, 2023 (7). 213. ISSN 1126-6708

Tumasyan, A. orcid.org/0009-0000-0684-6742, Adam, W. orcid.org/0000-0001-9099-4341, Andrejkovic, J.W. et al. (2348 more authors) (2023) Measurement of the mass dependence of the transverse momentum of lepton pairs in Drell–Yan production in proton–proton collisions at √s = 13 TeV. The European Physical Journal C, 83 (7). 628. ISSN 1434-6044

Proctor, V.K. orcid.org/0000-0001-6720-6773, O’Connor, O.M., Burns, F.A. et al. (114 more authors) (2023) Surgical site infections after emergency hernia repair: substudy from the Management of Acutely Symptomatic Hernia (MASH) study. BJS Open, 7 (1). zrac155. ISSN 2474-9842

Baltussen, R., Marsh, K., Thokala, P. orcid.org/0000-0003-4122-2366 et al. (20 more authors) (2019) Multicriteria decision analysis to support HTA agencies : benefits, limitations, and the way forward. Value in Health, 22 (11). pp. 1283-1288. ISSN 1098-3015

Crown, W., Buyukkaramikli, N., Sir, M.Y. et al. (7 more authors) (2018) Application of constrained optimization methods in health services research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force. Value in Health, 21 (9). pp. 1019-1028. ISSN 1098-3015

Rothman, A.M. orcid.org/0000-0002-7847-4500, Morton, A. and Crossman, D. (2018) Canakinumab for atherosclerotic disease. The New England Journal of Medicine, 378. pp. 196-200. ISSN 0028-4793

van Baal, P., Morton, A., Brouwer, W. et al. (2 more authors) (2017) Should cost effectiveness analyses for NICE always consider future unrelated medical costs? BMJ, 359. j5096. ISSN 0959-8138

Crown, W., Buyukkaramikli, N., Thokala, P. et al. (8 more authors) (2017) Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force. Value Health, 20 (3). pp. 310-319. ISSN 1098-3015

McCullagh, B.N., Costello, C.M., Li, L. et al. (9 more authors) (2015) Elevated plasma CXCL12 alpha is associated with a poorer prognosis in pulmonary arterial hypertension. PLoS ONE, 10 (4). e0123709. ISSN 1932-6203

Condliffe, R., Pickworth, J. orcid.org/0000-0002-7199-364X, Hopkinson, K. et al. (14 more authors) (2012) Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension. Pulmonary circulation, 2 (1). pp. 21-27. ISSN 2045-8932